Form 4: Disc Medicine CEO Reports Stock Transaction
Insider Transaction (Form 4)
John D Quisel, Chief Executive Officer and a Director of Disc Medicine, Inc., reported multiple transactions in common stock on September 15, 2026.
Summary
- Option exercise/conversion: acquired 36,000 Common Stock at $1.01 ($36,360) on September 15, 2026; holds 262,064 after (Direct).
- Option exercise/conversion: disposed of 36,000 Stock Option (Right to Buy) on September 15, 2026; holds 150,120 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John D Quisel — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Option exercise/conversion | Common Stock | 36,000 | $1 | $36.4K | 262,064 |
| 2026-09-15 | Option exercise/conversion | Stock Option (Right to Buy) | 36,000 | — | — | 150,120 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Option exercise/conversion (36,000 shares) |
| 2026-09-15 | Option exercise/conversion (36,000 shares) |
Keywords
insider transaction, Form 4, IRON, Disc Medicine, Inc., neutral, John D Quisel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.